ArticleIrish journal of medical science2026
Pancreatic duct stenting during pancreaticoduodenectomy: outcomes from a standardized duct-to-mucosa cohort with propensity score weighting.
Article in Irish journal of medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPostoperative pancreatic fistula (POPF) remains one of the most important complications after pancreaticoduodenectomy (PD), and the optimal transanastomotic pancreatic duct drainage strategy remains debated.
aimsTo evaluate the association between pancreatic duct stenting strategy and clinically relevant POPF (CR-POPF) after PD.
methodsWe retrospectively analyzed consecutive open PDs (2010-2020). Only patients undergoing standardized duct-to-mucosa pancreaticojejunostomy with a transanastomotic stent (external or internal) were included. The cohort comprised 302 patients (external n = 238; internal n = 64). The primary outcome was CR-POPF (ISGPS grade B-C). Propensity score-based inverse probability of treatment weighting (IPTW) was applied.
resultsCR-POPF occurred in 9.9% of patients and was lower with external versus internal stenting (8.0% vs. 17.2%, p = 0.029). Biliary leak was also less frequent with external stenting (4.6% vs. 14.1%, p = 0.019). In IPTW-weighted analysis, external stenting was independently associated with lower odds of CR-POPF (OR 0.31, 95% CI 0.14-0.70; p = 0.005). E-value analysis suggested moderate robustness to unmeasured confounding (E-value 5.9). Thirty-day mortality was numerically lower with external stenting (2.5% vs. 7.8%, p = 0.059).
conclusionsExternal pancreatic duct stenting was associated with lower CR-POPF rates after standardized PD. Prospective randomized studies are needed to confirm these findings and guide stenting strategy selection.
Indexed as
Identifiers
42423911What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.